Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
-
Correspondence: Michael John Fry M.J.Fry@reading.ac.uk
Breast Cancer Res 2001, 3:304-312 doi:10.1186/bcr312
Accesses
- Last 30 days: 81 accesses
- Last year: 952 accesses
- All time: 12234 accesses
Cited by
BioMed Central: 3 citations
|
Luminal-B breast cancer and novel therapeutic targets Ben Tran, Philippe L Bedard Breast Cancer Research 2011, 13:221 (30 November 2011) |
|
Xinqun Li, Yang Lu, Ke Liang, Bolin Liu, Zhen Fan Breast Cancer Research 2005, 7:R589-R597 (24 May 2005) |
|
New targets for therapy in breast cancer: Mammalian target of rapamycin (mTOR) antagonists Hetty Carraway, Manuel Hidalgo Breast Cancer Res 2004, 6:219-224 (12 August 2004) This article is part of a collection on New targets for therapy in... |